Company news

Sana Biotechnology, Inc. news in 2026

Sana Biotechnology, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Sana Biotechnology Reports Third Quarter 2026 Financial Results and Business Updates

November 5, 2026

Sana Biotechnology to Present at September 2026 Investor Conferences

September 1, 2026

Sana Biotechnology Reports Second Quarter 2026 Financial Results and Business Updates

August 10, 2026

Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes

July 13, 2026

Sana Biotechnology to Present at June 2026 Investor Conferences

May 27, 2026

Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility

May 15, 2026

Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs

May 12, 2026

Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates

May 10, 2026

Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference

May 5, 2026

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting

April 27, 2026

Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451

April 12, 2026

Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

March 12, 2026

Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

March 3, 2026

Sana Biotechnology to Present at March 2026 Investor Conferences

February 23, 2026

Sana Biotechnology Appoints Brian Piper as Executive Vice President, Chief Financial Officer

February 17, 2026

Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 7, 2026

Decks in 2026